Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

...

Div
classchevron
Div
classchevron-image

Candid photo of Kim Pelis, smiling outdoors

Div
classchevron-text

Dr. Kim Pelis Named ONHM Director

Dr. Pelis has worked at the NIH for more than 15 years, primarily in the Office of the Director, where she was lead speech writer on the NIH Director's Presentations Team and an editor for the NIH Director's Blog.  Kim joins the ONHM with experience in both academic and public history.  She earned her Ph.D. in the history of medicine from Johns Hopkins University School of Medicine.  Prior to coming to the NIH, Kim was an assistant professor of medical history at the Uniformed Services University, across the street from the NIH, from 1998 to 2005. 

...


Check Out our Oral Histories

Dive
preface
classgrid-row grid-gap
Dive
classgrid-col-8

Have you looked at our oral histories lately? New interviews with scientists, nurses, and administrators are being conducted and posted every month.

One of our newest oral histories is with Dr. Dominic Esposito, director of the Protein Expression Laboratory at NCI. Have you ever wondered how researchers get the raw materials to conduct experiments? In March 2020, Dr. Esposito was approached by NIH researchers who needed a constant supply of COVID-19 spike proteins to study how the virus works and build a vaccine.

“Figuring out how to run a group and to carry out this kind of research from home was a challenge, especially in the early days of the pandemic, when time was a factor and everybody was putting in 16-hour days. It was very difficult for me to be that far away and not…stand there in the lab and look at the data. That was a challenge, but frankly, it turned out to be a great opportunity. It made our group more efficient; we learned a lot of new technologies out of this.”


Dive
classgrid-col-4

Image Modified

Span
classcaption

Esposito shared this photo of cell Cell culture technician Kelly Snead separating separates final SARS-CoV-2 proteins into storage tubes for shipment to NIH researchers. 

...